JP2013507116A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013507116A5 JP2013507116A5 JP2012532656A JP2012532656A JP2013507116A5 JP 2013507116 A5 JP2013507116 A5 JP 2013507116A5 JP 2012532656 A JP2012532656 A JP 2012532656A JP 2012532656 A JP2012532656 A JP 2012532656A JP 2013507116 A5 JP2013507116 A5 JP 2013507116A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleotide sequence
- amino acid
- vaccine composition
- encoded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 17
- 102000004196 processed proteins & peptides Human genes 0.000 claims 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims 17
- 229960005486 vaccine Drugs 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 10
- 239000002773 nucleotide Substances 0.000 claims 9
- 125000003729 nucleotide group Chemical group 0.000 claims 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 230000000890 antigenic effect Effects 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 5
- 230000000813 microbial effect Effects 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 241000894007 species Species 0.000 claims 3
- 241000589180 Rhizobium Species 0.000 claims 2
- 241000194017 Streptococcus Species 0.000 claims 2
- 238000007792 addition Methods 0.000 claims 2
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 230000037430 deletion Effects 0.000 claims 2
- 238000012217 deletion Methods 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 230000002068 genetic effect Effects 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 241000908522 Borreliella Species 0.000 claims 1
- 241000223203 Coccidioides Species 0.000 claims 1
- 241000194032 Enterococcus faecalis Species 0.000 claims 1
- 241000590002 Helicobacter pylori Species 0.000 claims 1
- 241000228402 Histoplasma Species 0.000 claims 1
- 241000588748 Klebsiella Species 0.000 claims 1
- 241000219470 Mirabilis Species 0.000 claims 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 claims 1
- 241000588650 Neisseria meningitidis Species 0.000 claims 1
- 206010041925 Staphylococcal infections Diseases 0.000 claims 1
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- 241001147687 Staphylococcus auricularis Species 0.000 claims 1
- 241000191963 Staphylococcus epidermidis Species 0.000 claims 1
- 241001464905 Staphylococcus saccharolyticus Species 0.000 claims 1
- 241001147691 Staphylococcus saprophyticus Species 0.000 claims 1
- 241000192086 Staphylococcus warneri Species 0.000 claims 1
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229940032049 enterococcus faecalis Drugs 0.000 claims 1
- 229940037467 helicobacter pylori Drugs 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 244000144972 livestock Species 0.000 claims 1
- 239000007922 nasal spray Substances 0.000 claims 1
- 229940097496 nasal spray Drugs 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0917685.0 | 2009-10-09 | ||
| GBGB0917685.0A GB0917685D0 (en) | 2009-10-09 | 2009-10-09 | Antigenic polypeptide |
| PCT/GB2010/001722 WO2011042681A1 (en) | 2009-10-09 | 2010-09-13 | Staphylococcus aureus divi1b for use as vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013507116A JP2013507116A (ja) | 2013-03-04 |
| JP2013507116A5 true JP2013507116A5 (https=) | 2013-10-31 |
| JP5963674B2 JP5963674B2 (ja) | 2016-08-03 |
Family
ID=41402763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012532656A Expired - Fee Related JP5963674B2 (ja) | 2009-10-09 | 2010-09-13 | Ａｓワクチンとして使用するための黄色ブドウ球菌ｄｉｖｉ１ｂ |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8691242B2 (https=) |
| EP (1) | EP2485757A1 (https=) |
| JP (1) | JP5963674B2 (https=) |
| CN (1) | CN102481353B (https=) |
| AU (1) | AU2010304915B2 (https=) |
| CA (1) | CA2775997A1 (https=) |
| GB (1) | GB0917685D0 (https=) |
| WO (1) | WO2011042681A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201206366D0 (en) * | 2012-04-11 | 2012-05-23 | Absynth Biologics Ltd | Bacterial vaccine |
| GB201417214D0 (en) | 2014-09-30 | 2014-11-12 | Absynth Biologics Ltd | Vaccine |
| CN116904356A (zh) * | 2022-06-22 | 2023-10-20 | 浙江省农业科学院 | 模仿葡萄球菌hz01菌剂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6022706A (en) * | 1997-04-09 | 2000-02-08 | Smithkline Beecham Corporation | Div1b |
| US5955304A (en) * | 1997-01-02 | 1999-09-21 | Smithkline Beecham Corporation | DivIB |
| AU2002306849A1 (en) * | 2001-03-21 | 2002-10-08 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
| GB0107661D0 (en) * | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
| ES2504166T3 (es) * | 2002-09-13 | 2014-10-08 | Novartis Vaccines And Diagnostics, Inc. | Vacuna de estreptococo del grupo B |
| GB0409559D0 (en) * | 2004-04-29 | 2004-06-02 | Univ Sheffield | Polypeptide |
| GB0505949D0 (en) * | 2005-03-23 | 2005-04-27 | Univ Sheffield | Polypeptides |
-
2009
- 2009-10-09 GB GBGB0917685.0A patent/GB0917685D0/en not_active Ceased
-
2010
- 2010-09-13 AU AU2010304915A patent/AU2010304915B2/en not_active Ceased
- 2010-09-13 CN CN201080039459.2A patent/CN102481353B/zh not_active Expired - Fee Related
- 2010-09-13 WO PCT/GB2010/001722 patent/WO2011042681A1/en not_active Ceased
- 2010-09-13 EP EP10765827A patent/EP2485757A1/en not_active Withdrawn
- 2010-09-13 US US13/500,292 patent/US8691242B2/en not_active Expired - Fee Related
- 2010-09-13 JP JP2012532656A patent/JP5963674B2/ja not_active Expired - Fee Related
- 2010-09-13 CA CA2775997A patent/CA2775997A1/en not_active Abandoned
-
2014
- 2014-02-06 US US14/174,807 patent/US20140161835A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rosini et al. | Vaccines against antimicrobial resistance | |
| Lipsitch et al. | How can vaccines contribute to solving the antimicrobial resistance problem? | |
| Bitrus et al. | Staphylococcus aureus: A review of antimicrobial resistance mechanisms | |
| Holmes et al. | What's new in the treatment of serious MRSA infection? | |
| Munoz et al. | Linezolid therapy for infective endocarditis | |
| Mat Rahim et al. | Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development | |
| DE60227157D1 (de) | Impstoffe zur transkutanen immunisierung gegen reisediarrhö | |
| JP2013539751A5 (https=) | ||
| JP2012513467A5 (https=) | ||
| Innamorati et al. | The bacterial guide to designing a diversified gene portfolio | |
| JP2013507116A5 (https=) | ||
| Joice et al. | Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance | |
| Fraser et al. | Application of microbial genomic science to advanced therapeutics | |
| JP5963674B2 (ja) | Ａｓワクチンとして使用するための黄色ブドウ球菌ｄｉｖｉ１ｂ | |
| WO2009077744A3 (en) | Vaccines for brucellosis | |
| Nathawat et al. | Characterization of Staphylococcus aureus of goat mastitis milk origin for cap and clfA genes | |
| Hadi et al. | Genome sequences of Mycobacterium tuberculosis biovar bovis strains Ravenel and 10-7428 | |
| EP1740206B1 (en) | Phep, an amino acid permease of staphylococcus aureus | |
| AR107813A1 (es) | Partículas de liberación de fármacos, procedimiento, composición inmunogénica, dispositivo, uso, vacuna | |
| US20160184421A1 (en) | Immunotherapeutic targets against staphylococcus aureus | |
| Premkrishnan et al. | Complete genome sequence of Staphylococcus haemolyticus type strain SGAir0252. Genome Announc 6: e00229-18 | |
| Bae et al. | In silico Design of Multi-epitope Vaccines Targeting Iron-regulated lipoproteins of Staphylococcus aureus Using Immunoinformactics | |
| Farhab et al. | Staphylococcus aureus and the Veterinary Medicine | |
| Chopra et al. | Emerging Antimicrobial Resistance in Staphylococcus and Spectrum of Oral Oxazolidinone Linezolid in Multidrug Resistant Staphylococcus in a Tertiary Care Hospital | |
| Lindsay et al. | The staphylococci: a postgenomic view |